AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17071935
Drug: GEM 1000
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GEM 1000 mg/m(2) and PTX 125 mg/m(2) on days 1 and 8 (GT arm)
Trial: 25436225
Drug: Scoliosis-specific exercise
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scoliosis-specific exercise treatment
Trial: 27524882
Drug: Weekly paclitaxel
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Weekly paclitaxel (wPTX) plus valproic acid (VPA)
Trial: 11429003
Drug: Oral ganciclovir
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ganciclovir (2 g daily for 2-3 months) following 14-21 days of intravenous ganciclovir (5 mg/kg b.i.d.)
Trial: 8181883
Drug: Transdermal nitrate
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal nitrate therapy (0.4 mg/h)
Trial: 30679095
Drug: Oral insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral insulin 338 (I338)
Trial: 17909953
Drug: Flebogamma 5%
RxNorm normalized name: Flebogamma 5% 5g Solution for Injection
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flebogamma 5% DIF administered at a dose of 300‐600 mg/kg every 21‐28 days for 12 months
Trial: 25173754
Drug: Infliximab therapy
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Infliximab therapy
Trial: 9106017
Drug: Clarithromycin at
RxNorm normalized name: Clarithromycin
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clarithromycin at 15 mg/kg per day divided into two equal doses for 10 days
Trial: 31993781
Drug: Ofatumumab (OFA)
RxNorm normalized name: Ofatumumab
DrugBank: Ofatumumab (DB06650)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ofatumumab (OFA) 1500 mg/1.73 m2
Trial: 20124169
Drug: Conventional-dose radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional-dose radiation therapy (70.2 GyE)
Trial: 7554338
Drug: Topical salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical salbutamol
Trial: 25107879
Drug: telcagepant 140
RxNorm normalized name: Telcagepant
DrugBank: Telcagepant (DB12228)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: telcagepant 140 mg
Trial: 21457238
Drug: telcagepant 280
RxNorm normalized name: Telcagepant
DrugBank: Telcagepant (DB12228)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: telcagepant 280 mg
Trial: 8353547
Drug: Antibiotic plus
RxNorm normalized name: Triple Antibiotic Plus
DrugBank: Polymyxin B (DB00781)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antibiotic plus laser therapy (group II)
Trial: 27727138
Drug: Interactive online
RxNorm normalized name: Menin-mll interaction inhibitor ko 539
DrugBank: Ziftomenib (DB17171)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interactive online curriculum with weekly reading assignments (GROUP 1)
Trial: 26558724
Drug: MVA-B vaccine
RxNorm normalized name: MVA-BN-brachyury-TRICOM vaccine
DrugBank: MVA-BN-brachyury-TRICOM vaccine (DB17424)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MVA-B vaccine
Trial: 30235286
Drug: VSV-Gag vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VSV-Gag vaccine (3.4 ⊆ 107 PFU) given at 6 months after the initial vaccination.
Trial: 17993028
Drug: Crest Vivid
RxNorm normalized name: Crest
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Crest Vivid White whitening dentifrice used twice daily
Trial: 11773839
Drug: 3-minute daily
RxNorm normalized name: diclofenac
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3-minute daily treatments for 2 weeks before surgery (Group B)
Trial: 26875198
Drug: Imatinib mesylate
RxNorm normalized name: Imatinib Mesylate
DrugBank: Imatinib (DB00619)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Imatinib mesylate 400 mg tablets (test formulation)
Trial: 26317782
Drug: Hydrocortisone (HC)
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone (HC) at doses of 6 mg/m2/d, 10 mg/m2/d, and 14 mg/m2/d administered thrice daily.
Trial: 27265844
Drug: Testosterone gel
RxNorm normalized name: Androgel 1.62% Metered Dose Pump Testosterone Gel
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone gel (TRT, n = 20)
Trial: 23695200
Drug: Short-term treatment
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term treatment with 40 mg of prednisone daily for 5 days
Trial: 8312826
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with zidovudine (AZT) and dideoxycytidine (ddC)
Trial: 23695200
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment with 40 mg of prednisone daily for 14 days
Trial: 29660425
Drug: Etanercept 50
RxNorm normalized name: etanercept 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 50 mg twice weekly for 12 weeks
Trial: 28784554
Drug: Ab interno
RxNorm normalized name: Crotalidae immune F(ab')2 Injection [Anavip]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ab interno gelatin stent (XEN 45 Gel Stent)
Trial: 30926104
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (orthodontic treatment only)
Trial: 24334179
Drug: Crofelemer 125
RxNorm normalized name: crofelemer 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crofelemer 125 mg twice daily
Trial: 19858812
Drug: Interprofessional team
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interprofessional team care (primary care internal medicine residents, nurse practitioner students, pharmacy students)
Trial: 25703961
Drug: Riociguat up
RxNorm normalized name: Riociguat
DrugBank: Riociguat (DB08931)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Riociguat up to 2.5 mg 3 times daily
Trial: 18516002
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (intravenous and oral placebo)
Trial: 16242376
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of hypertonic saline into the lumbar multifidus muscle
Trial: 16751657
Drug: Dexamethasone 10
RxNorm normalized name: dexamethasone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 10 mg per day for 1 day (Group B)
Trial: 12543995
Drug: Home-delivered physical
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Home-delivered physical and occupational therapy (PT), n = 26, no supervised exercise
Trial: 18498921
Drug: Doripenem 500
RxNorm normalized name: doripenem 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doripenem 500 mg q8h i.v. (4-hour infusion)
Trial: 21444712
Drug: FV-100 100
RxNorm normalized name: HORSERADISH 10 g in 100 mL TOPICAL LIQUID [NWK A-FV]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FV-100 100 mg once daily (QD) for 7 days
Trial: 21444712
Drug: FV-100 400
RxNorm normalized name: HORSERADISH 10 g in 100 mL TOPICAL LIQUID [NWK A-FV]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FV-100 400 mg QD for 7 days
Trial: 10905488
Drug: IGF-I treatment
RxNorm normalized name: iobenguane I-131
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IGF-I treatment (40 microg x kg(‐1) x day(‐1))
Trial: 10667623
Drug: No oral
RxNorm normalized name: Beano Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No oral support (control group)
Trial: 18245406
Drug: Sterile water
RxNorm normalized name: sterile water
DrugBank: Water (DB09145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sterile water control solution
Trial: 15789278
Drug: Biphasic human
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Biphasic human insulin (BHI30)
Trial: 19395466
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg granisetron
Trial: 16372518
Drug: Zinc oxide
RxNorm normalized name: Zinc Oxide
DrugBank: Zinc oxide (DB09321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zinc oxide (17.4 mg metal zinc)
Trial: 6960390
Drug: PGE2 0.5
RxNorm normalized name: PGE2 0.5 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGE2 0.5 mg three times daily and 1 mg at night
Trial: 17460371
Drug: telmisartan 80
RxNorm normalized name: telmisartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: telmisartan 80 mg/day
Trial: 9744490
Drug: Megestrol acetate
RxNorm normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megestrol acetate 160 mg
Trial: 25420897
Drug: Racotumomab-alum vaccine
RxNorm normalized name: alum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Racotumomab-alum vaccine
Trial: 23337183
Drug: Self-help Acceptance
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-help Acceptance and Commitment Therapy (ACT) with e-mail support
Trial: 31397943
Drug: bleselumab 200
RxNorm normalized name: Bleselumab
DrugBank: Bleselumab (DB15253)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bleselumab 200 mg
Trial: 20140619
Drug: Short-term therapy
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term therapy (4 days)
Trial: 26321708
Drug: Longer treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Longer treatment period of sorafenib
Trial: 7963139
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C supplementation (100 or 600 mg daily for 58 days)
Trial: 29162361
Drug: Oral glucose
RxNorm normalized name: glucose Oral Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral glucose tolerance tests (OGTTs) with 25, 75, and 125 g glucose
Trial: 16194311
Drug: Glutamine granules
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glutamine granules (0.5 g.kg(‐1).d(‐1) for 7 days)
Trial: 30795492
Drug: Risperidone adjunct
RxNorm normalized name: Risperidone
DrugBank: Risperidone (DB00734)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Risperidone adjunct therapy for 52 weeks
Trial: 2653395
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium slow release (DSR) 100 mg daily
Trial: 20634296
Drug: Urinary Albumin
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urinary Albumin Excretion (UAE)
Trial: 20634296
Drug: Urinary Protein
RxNorm normalized name: Urinary protein of low molecular weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urinary Protein Excretion (UPE)
Trial: 9653702
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no treatment, next IVF-ET performed within six months after previous failed cycle)
Trial: 8138680
Drug: E5 (edobacomab)
RxNorm normalized name: HYDROXYPROPYL METHYLCELLULOSE E5 [II]
DrugBank: Edobacomab (DB17779)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E5 (edobacomab) 1 mg/kg
Trial: 25216712
Drug: Sunflower oil
RxNorm normalized name: Sunflower Oil
DrugBank: Sunflower oil (DB14329)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sunflower oil (linoleic acid; 10 g LA/day)
Trial: 11421189
Drug: Supervised physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervised physical therapy rehabilitation (one hour, twice weekly) with emphasis on balance training
Trial: 9402175
Drug: Second-line treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second-line treatment for relapsing patients
Trial: 10928578
Drug: Gabapentin 3600
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gabapentin 3600 mg per day
Trial: 15184611
Drug: Natalizumab 3
RxNorm normalized name: natalizumab 300 MG in 15 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natalizumab 3 mg/kg
Trial: 10102948
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg once daily for 2 weeks
Trial: 28805601
Drug: Combined oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined oral contraceptive pills (COC) containing 30 μg of EE and 3 mg of drospirenone for 12 consecutive cycles
Trial: 1095098
Drug: 200 rads
RxNorm normalized name: RAD-IFN
DrugBank: Nadofaragene firadenovec (DB17381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 rads daily five times weekly for four weeks
Trial: 24298762
Drug: Theophylline sustained
RxNorm normalized name: Theophylline
DrugBank: Theophylline (DB00277)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Theophylline sustained release tablet combined with oxygen uptake, aerosol inhalation, and oral administration of prednisone
Trial: 19967563
Drug: n-3 fatty
RxNorm normalized name: n-3 fatty acids
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 fatty acids (900 mg per day for 6 months)
Trial: 16109326
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 48 mg/min
Trial: 15073669
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg famciclovir 3 times daily
Trial: 9380326
Drug: Oral beta
RxNorm normalized name: Cloral betaine
DrugBank: Chloral betaine (DB01494)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral beta carotene for at least 6 months
Trial: 17309456
Drug: Ketoconazole 2%
RxNorm normalized name: KETOCONAZOLE 2% CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole 2% cream
Trial: 8884758
Drug: Alprazolam (APZ)
RxNorm normalized name: Alprazolam
DrugBank: Alprazolam (DB00404)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alprazolam (APZ) 1 mg/day orally for 3 days
Trial: 7688774
Drug: Capsaicin 0.025%
RxNorm normalized name: CAPSAICIN 0.025% CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsaicin 0.025% cream
Trial: 30592353
Drug: Cardiac resynchronization
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac resynchronization therapy with defibrillator (CRT-D)
Trial: 23135345
Drug: Teriparatide 20
RxNorm normalized name: TERIPARATIDE 200UNT/VIL INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teriparatide 20 μg/day
Trial: 27422279
Drug: 9vHPV vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9vHPV vaccine
Trial: 9631991
Drug: Fluconazole 450
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole 450 mg once weekly for 4 months
Trial: 9631991
Drug: Fluconazole 450
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole 450 mg once weekly for 6 months
Trial: 15152493
Drug: Antiplatelet therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiplatelet therapy (low dose aspirin 75 to 150 mg)
Trial: 17526461
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (500 mg)
Trial: 18471515
Drug: IC41 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IC41 vaccine (3 different dose groups)
Trial: 21709132
Drug: Health care
RxNorm normalized name: Health Care Lancing Device
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Health care providers' written prescriptions for physical activity without additional physical activity resources
Trial: 28754306
Drug: Deep Brain
RxNorm normalized name: pork brain preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deep Brain Stimulation (DBS) of the ventral anterior limb of the internal capsule (vALIC)
Trial: 12947997
Drug: Injection immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection immunotherapy
Trial: 27410922
Drug: Olanzapine 10
RxNorm normalized name: olanzapine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine 10 mg orally daily on days 1 through 4
Trial: 3653766
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of cyclophosphamide, doxorubicin, and cisplatin (CAP) 400 mg/m2, 40 mg/m2, and 40 mg/m2 respectively every 4 weeks
Trial: 24712573
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 (50,000 IU weekly for 8 weeks)
Trial: 23124178
Drug: Solution-Focused Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solution-Focused Therapy (SFT)
Trial: 22971528
Drug: Cupping therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cupping therapy
Trial: 24612661
Drug: Celecoxib added
RxNorm normalized name: Celecoxib
DrugBank: Celecoxib (DB00482)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Celecoxib added to standard treatment
Trial: 24868083
Drug: Fixed dose
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed dose combination treatment
Trial: 12121563
Drug: Low-dose meglumine
RxNorm normalized name: Meglumine
DrugBank: Meglumine (DB09415)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low-dose meglumine antimoniate (MA) at 60 mg/kg/day for 20 days
Trial: 23070803
Drug: Quetiapine XR
RxNorm normalized name: quetiapine Extended Release Oral Tablet
DrugBank: Quetiapine (DB01224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quetiapine XR (50-300 mg/day)
Trial: 17458428
Drug: Delayed bronchial
RxNorm normalized name: Bronchitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Delayed bronchial and patch response
Trial: 11506402
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone
Trial: 2213104
Drug: Combined chemo-endocrine
RxNorm normalized name: Chem-Star Recover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined chemo-endocrine therapy (initial treatment)
Trial: 26605507
Drug: Live varicella
RxNorm normalized name: varicella, live attenuated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live varicella zoster vaccine
Trial: 27716159
Drug: Corticosteroid injection
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injection (20 mg Depo-Medrone)
Trial: 10540058
Drug: Rectal diclofenac
RxNorm normalized name: diclofenac Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal diclofenac 100 mg immediately post-induction
Trial: 27265181
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein + 3 g HMB (HMB)
Trial: 9087387
Drug: Interferon-gamma (IFN-gamma)
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-gamma (IFN-gamma) therapy
Trial: 20061838
Drug: Gabapentin monotherapy
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gabapentin monotherapy
Trial: 21309476
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg plain bupivacaine plus 35 mg meperidine (BM35)
Trial: 26361756
Drug: Radial Extracorporeal
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radial Extracorporeal Shock Wave Therapy (rESWT) combined with supervised exercises (SE)
Trial: 10932511
Drug: Cyproterone acetate
RxNorm normalized name: cyproterone acetate
DrugBank: Cyproterone acetate (DB04839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyproterone acetate 1 mg/day
Trial: 17311617
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid 1 mg/day for 6 months
Trial: 11503945
Drug: Pyridostigmine bromide
RxNorm normalized name: Pyridostigmine Bromide
DrugBank: Pyridostigmine (DB00545)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pyridostigmine bromide (30 mg orally)
Trial: 11899388
Drug: Paclitaxel 175
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 175 mg/m2 given as a 3-hour infusion every 3 weeks